These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32361662)

  • 1. Prospective longitudinal patient-reported outcomes of swallowing following intensity modulated proton therapy for oropharyngeal cancer.
    Grant SR; Hutcheson KA; Ye R; Garden AS; Morrison WH; Rosenthal DI; Brandon Gunn G; Fuller CD; Phan J; Reddy JP; Moreno AC; Lewin JS; Sturgis EM; Ferrarotto R; Frank SJ
    Radiother Oncol; 2020 Jul; 148():133-139. PubMed ID: 32361662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma.
    Goepfert RP; Lewin JS; Barrow MP; Fuller CD; Lai SY; Song J; Hobbs BP; Gunn GB; Beadle BM; Rosenthal DI; Garden AS; Kies MS; Papadimitrakopoulou VA; Schwartz DL; Hutcheson KA
    Laryngoscope; 2017 Apr; 127(4):842-848. PubMed ID: 27440393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term, Prospective Performance of the MD Anderson Dysphagia Inventory in "Low-Intermediate Risk" Oropharyngeal Carcinoma After Intensity Modulated Radiation Therapy.
    Goepfert RP; Lewin JS; Barrow MP; Gunn GB; Fuller CD; Beadle BM; Garden AS; Rosenthal DI; Kies MS; Papadimitrakopoulou V; Lai SY; Gross ND; Schwartz DL; Hutcheson KA
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):700-708. PubMed ID: 27485284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensity Modulated Proton Therapy Versus Intensity Modulated Photon Radiation Therapy for Oropharyngeal Cancer: First Comparative Results of Patient-Reported Outcomes.
    Sio TT; Lin HK; Shi Q; Gunn GB; Cleeland CS; Lee JJ; Hernandez M; Blanchard P; Thaker NG; Phan J; Rosenthal DI; Garden AS; Morrison WH; Fuller CD; Mendoza TR; Mohan R; Wang XS; Frank SJ
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1107-14. PubMed ID: 27354125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-item discrimination of quality-of-life-altering dysphagia among 714 long-term oropharyngeal cancer survivors: Comparison of patient-reported outcome measures of swallowing.
    ; Grant S; Kamal M; Mohamed ASR; Zaveri J; Barrow MP; Gunn GB; Lai SY; Lewin JS; Rosenthal DI; Wang XS; Fuller CD; Hutcheson KA
    Cancer; 2019 May; 125(10):1654-1664. PubMed ID: 30633325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-reported outcomes following parotid-sparing intensity-modulated radiotherapy for head and neck cancer. How important is dysphagia?
    Roe JW; Drinnan MJ; Carding PN; Harrington KJ; Nutting CM
    Oral Oncol; 2014 Dec; 50(12):1182-7. PubMed ID: 25448227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-Reported Outcomes After Swallowing (SWOARs)-Sparing IMRT in Head and Neck Cancers: Primary Results from a Prospective Study Endorsed by the Head and Neck Study Group (HNSG) of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
    Ursino S; Calistri E; De Felice F; Bonomo P; Desideri I; Franco P; Arcadipane F; Colosimo C; Mazzola R; Maddalo M; Gonnelli A; Malfatti G; Morganti R; Musio D; Paiar F
    Dysphagia; 2023 Feb; 38(1):159-170. PubMed ID: 35587295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetric advantages of intensity-modulated proton therapy for oropharyngeal cancer compared with intensity-modulated radiation: A case-matched control analysis.
    Holliday EB; Kocak-Uzel E; Feng L; Thaker NG; Blanchard P; Rosenthal DI; Gunn GB; Garden AS; Frank SJ
    Med Dosim; 2016; 41(3):189-94. PubMed ID: 27158021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Outcomes and Patterns of Disease Recurrence After Intensity Modulated Proton Therapy for Oropharyngeal Squamous Carcinoma.
    Gunn GB; Blanchard P; Garden AS; Zhu XR; Fuller CD; Mohamed AS; Morrison WH; Phan J; Beadle BM; Skinner HD; Sturgis EM; Kies MS; Hutcheson KA; Rosenthal DI; Mohan R; Gillin MT; Frank SJ
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):360-367. PubMed ID: 27084653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Quantitative Clinical Decision-Support Strategy Identifying Which Patients With Oropharyngeal Head and Neck Cancer May Benefit the Most From Proton Radiation Therapy.
    Brodin NP; Kabarriti R; Pankuch M; Schechter CB; Gondi V; Kalnicki S; Guha C; Garg MK; Tomé WA
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):540-552. PubMed ID: 30496877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of Patient-Reported Dysphagia Following IMRT Plus Chemotherapy in Oropharyngeal Cancer.
    Orlandi E; Miceli R; Infante G; Mirabile A; Alterio D; Cossu Rocca M; Denaro N; Vigna-Taglianti R; Merlotti A; Schindler A; Pizzorni N; Fallai C; Licitra L; Bossi P
    Dysphagia; 2019 Feb; 34(1):52-62. PubMed ID: 29948260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of acute toxicities and patient reported outcomes between intensity-modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) for the treatment of oropharyngeal cancer.
    Manzar GS; Lester SC; Routman DM; Harmsen WS; Petersen MM; Sloan JA; Mundy DW; Hunzeker AE; Amundson AC; Anderson JL; Patel SH; Garces YI; Halyard MY; McGee LA; Neben-Wittich MA; Ma DJ; Frank SJ; Whitaker TJ; Foote RL
    Radiother Oncol; 2020 Jun; 147():64-74. PubMed ID: 32234612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term patient reported swallowing function following chemoradiotherapy for oropharyngeal carcinoma.
    Dixon L; Ramasamy S; Cardale K; Dyker K; Garcez K; Lee LW; McPartlin A; Murray P; Sen M; Slevin N; Sykes A; Prestwich R; Thomson D
    Radiother Oncol; 2018 Sep; 128(3):452-458. PubMed ID: 29937211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensity-modulated proton therapy and osteoradionecrosis in oropharyngeal cancer.
    Zhang W; Zhang X; Yang P; Blanchard P; Garden AS; Gunn B; Fuller CD; Chambers M; Hutcheson KA; Ye R; Lai SY; Radwan MAS; Zhu XR; Frank SJ
    Radiother Oncol; 2017 Jun; 123(3):401-405. PubMed ID: 28549794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Objective Ratings of Swallowing and Dysphagia-Specific Quality of Life in Patients Receiving (Chemo)radiotherapy for Oropharyngeal Cancer.
    Wishart LR; Harris GB; Cassim N; Alimin S; Liao T; Brown B; Ward EC; Nund RL
    Dysphagia; 2022 Aug; 37(4):1014-1021. PubMed ID: 34625841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy.
    Schwartz DL; Hutcheson K; Barringer D; Tucker SL; Kies M; Holsinger FC; Ang KK; Morrison WH; Rosenthal DI; Garden AS; Dong L; Lewin JS
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1356-65. PubMed ID: 20646872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in Patient-reported Swallow Function in the Long Term After Chemoradiotherapy for Oropharyngeal Carcinoma.
    Martin A; Murray L; Sethugavalar B; Buchan C; Williams GF; Sen M; Prestwich RJD
    Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):756-763. PubMed ID: 30025978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results.
    Feng FY; Kim HM; Lyden TH; Haxer MJ; Worden FP; Feng M; Moyer JS; Prince ME; Carey TE; Wolf GT; Bradford CR; Chepeha DB; Eisbruch A
    J Clin Oncol; 2010 Jun; 28(16):2732-8. PubMed ID: 20421546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: A planning comparative study.
    van der Laan HP; van de Water TA; van Herpt HE; Christianen ME; Bijl HP; Korevaar EW; Rasch CR; van 't Veld AA; van der Schaaf A; Schilstra C; Langendijk JA;
    Acta Oncol; 2013 Apr; 52(3):561-9. PubMed ID: 22708528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-reported outcomes in terms of swallowing and quality of life after prophylactic versus reactive percutaneous endoscopic gastrostomy tube placement in advanced oropharyngeal cancer patients treated with definitive chemo-radiotherapy: Swall PEG study.
    Dragan T; Van Gossum A; Duprez F; Lalami Y; Lefebvre Y; Mootassim-Billah S; Beauvois S; Gulyban A; Vandekerkhove C; Boegner P; Paesmans M; Ameye L; Digonnet A; Quiriny M; Dequanter D; Lipski S; Willemse E; Rodriguez A; Carlot S; Karaca Y; Lemort M; Emonts P; Al Wardi C; Van Gestel D
    Trials; 2022 Dec; 23(1):1036. PubMed ID: 36539781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.